nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP1A2—chronic obstructive pulmonary disease	0.448	1	CbGaD
Mexiletine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0737	0.205	CbGbCtD
Mexiletine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0426	0.119	CbGbCtD
Mexiletine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0413	0.115	CbGbCtD
Mexiletine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0413	0.115	CbGbCtD
Mexiletine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0368	0.103	CbGbCtD
Mexiletine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0347	0.0966	CbGbCtD
Mexiletine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0234	0.0653	CbGbCtD
Mexiletine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0223	0.0623	CbGbCtD
Mexiletine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0199	0.0555	CbGbCtD
Mexiletine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0117	0.0326	CbGbCtD
Mexiletine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.011	0.0307	CbGbCtD
Mexiletine—Tocainide—CYP1A2—chronic obstructive pulmonary disease	0.00173	0.634	CrCbGaD
Mexiletine—Tocainide—ALB—chronic obstructive pulmonary disease	0.000999	0.366	CrCbGaD
Mexiletine—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000488	0.00345	CcSEcCtD
Mexiletine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000488	0.00345	CcSEcCtD
Mexiletine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000484	0.00342	CcSEcCtD
Mexiletine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000484	0.00342	CcSEcCtD
Mexiletine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000484	0.00342	CcSEcCtD
Mexiletine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000473	0.00334	CcSEcCtD
Mexiletine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000471	0.00333	CcSEcCtD
Mexiletine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000471	0.00333	CcSEcCtD
Mexiletine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000469	0.00331	CcSEcCtD
Mexiletine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000465	0.00329	CcSEcCtD
Mexiletine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000465	0.00328	CcSEcCtD
Mexiletine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000464	0.00328	CcSEcCtD
Mexiletine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000464	0.00328	CcSEcCtD
Mexiletine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000462	0.00327	CcSEcCtD
Mexiletine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00046	0.00325	CcSEcCtD
Mexiletine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000456	0.00323	CcSEcCtD
Mexiletine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000455	0.00321	CcSEcCtD
Mexiletine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.00318	CcSEcCtD
Mexiletine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00045	0.00318	CcSEcCtD
Mexiletine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.00317	CcSEcCtD
Mexiletine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000449	0.00317	CcSEcCtD
Mexiletine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000446	0.00315	CcSEcCtD
Mexiletine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000446	0.00315	CcSEcCtD
Mexiletine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.00314	CcSEcCtD
Mexiletine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00312	CcSEcCtD
Mexiletine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00312	CcSEcCtD
Mexiletine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000438	0.0031	CcSEcCtD
Mexiletine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.00308	CcSEcCtD
Mexiletine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000433	0.00306	CcSEcCtD
Mexiletine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000432	0.00305	CcSEcCtD
Mexiletine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.00304	CcSEcCtD
Mexiletine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00043	0.00304	CcSEcCtD
Mexiletine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00301	CcSEcCtD
Mexiletine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00301	CcSEcCtD
Mexiletine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.003	CcSEcCtD
Mexiletine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.003	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000423	0.00299	CcSEcCtD
Mexiletine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000421	0.00297	CcSEcCtD
Mexiletine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.00297	CcSEcCtD
Mexiletine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000417	0.00294	CcSEcCtD
Mexiletine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00294	CcSEcCtD
Mexiletine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00292	CcSEcCtD
Mexiletine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00292	CcSEcCtD
Mexiletine—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00292	CcSEcCtD
Mexiletine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.00289	CcSEcCtD
Mexiletine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00287	CcSEcCtD
Mexiletine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00286	CcSEcCtD
Mexiletine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00286	CcSEcCtD
Mexiletine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00284	CcSEcCtD
Mexiletine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.00284	CcSEcCtD
Mexiletine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000397	0.00281	CcSEcCtD
Mexiletine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000397	0.0028	CcSEcCtD
Mexiletine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000396	0.0028	CcSEcCtD
Mexiletine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.0028	CcSEcCtD
Mexiletine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00276	CcSEcCtD
Mexiletine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000391	0.00276	CcSEcCtD
Mexiletine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000391	0.00276	CcSEcCtD
Mexiletine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000391	0.00276	CcSEcCtD
Mexiletine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000391	0.00276	CcSEcCtD
Mexiletine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000389	0.00275	CcSEcCtD
Mexiletine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00275	CcSEcCtD
Mexiletine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00275	CcSEcCtD
Mexiletine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00275	CcSEcCtD
Mexiletine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00273	CcSEcCtD
Mexiletine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00273	CcSEcCtD
Mexiletine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.00271	CcSEcCtD
Mexiletine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000383	0.0027	CcSEcCtD
Mexiletine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.0027	CcSEcCtD
Mexiletine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000382	0.0027	CcSEcCtD
Mexiletine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00269	CcSEcCtD
Mexiletine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00268	CcSEcCtD
Mexiletine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000378	0.00267	CcSEcCtD
Mexiletine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00265	CcSEcCtD
Mexiletine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00265	CcSEcCtD
Mexiletine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00264	CcSEcCtD
Mexiletine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00261	CcSEcCtD
Mexiletine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00261	CcSEcCtD
Mexiletine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00259	CcSEcCtD
Mexiletine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000367	0.00259	CcSEcCtD
Mexiletine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00257	CcSEcCtD
Mexiletine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000362	0.00256	CcSEcCtD
Mexiletine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00255	CcSEcCtD
Mexiletine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00254	CcSEcCtD
Mexiletine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.0025	CcSEcCtD
Mexiletine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00035	0.00247	CcSEcCtD
Mexiletine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00035	0.00247	CcSEcCtD
Mexiletine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.00247	CcSEcCtD
Mexiletine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00246	CcSEcCtD
Mexiletine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.00245	CcSEcCtD
Mexiletine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000342	0.00242	CcSEcCtD
Mexiletine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00242	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00241	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00241	CcSEcCtD
Mexiletine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000337	0.00238	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00236	CcSEcCtD
Mexiletine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00236	CcSEcCtD
Mexiletine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00236	CcSEcCtD
Mexiletine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00235	CcSEcCtD
Mexiletine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00235	CcSEcCtD
Mexiletine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000331	0.00234	CcSEcCtD
Mexiletine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00233	CcSEcCtD
Mexiletine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00233	CcSEcCtD
Mexiletine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00233	CcSEcCtD
Mexiletine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00233	CcSEcCtD
Mexiletine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000326	0.0023	CcSEcCtD
Mexiletine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.0023	CcSEcCtD
Mexiletine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00228	CcSEcCtD
Mexiletine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000323	0.00228	CcSEcCtD
Mexiletine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.00228	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00228	CcSEcCtD
Mexiletine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00032	0.00226	CcSEcCtD
Mexiletine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00032	0.00226	CcSEcCtD
Mexiletine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.00226	CcSEcCtD
Mexiletine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.00226	CcSEcCtD
Mexiletine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00225	CcSEcCtD
Mexiletine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00224	CcSEcCtD
Mexiletine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00223	CcSEcCtD
Mexiletine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00223	CcSEcCtD
Mexiletine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00222	CcSEcCtD
Mexiletine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00222	CcSEcCtD
Mexiletine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.00221	CcSEcCtD
Mexiletine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.0022	CcSEcCtD
Mexiletine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.00219	CcSEcCtD
Mexiletine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.00219	CcSEcCtD
Mexiletine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00218	CcSEcCtD
Mexiletine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00218	CcSEcCtD
Mexiletine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.00218	CcSEcCtD
Mexiletine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.00217	CcSEcCtD
Mexiletine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00216	CcSEcCtD
Mexiletine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00216	CcSEcCtD
Mexiletine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00215	CcSEcCtD
Mexiletine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00214	CcSEcCtD
Mexiletine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00214	CcSEcCtD
Mexiletine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00212	CcSEcCtD
Mexiletine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00209	CcSEcCtD
Mexiletine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00209	CcSEcCtD
Mexiletine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00209	CcSEcCtD
Mexiletine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00209	CcSEcCtD
Mexiletine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.00208	CcSEcCtD
Mexiletine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000293	0.00207	CcSEcCtD
Mexiletine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00207	CcSEcCtD
Mexiletine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000292	0.00207	CcSEcCtD
Mexiletine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000292	0.00206	CcSEcCtD
Mexiletine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00206	CcSEcCtD
Mexiletine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.00205	CcSEcCtD
Mexiletine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.00205	CcSEcCtD
Mexiletine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00205	CcSEcCtD
Mexiletine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00205	CcSEcCtD
Mexiletine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00204	CcSEcCtD
Mexiletine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00197	CcSEcCtD
Mexiletine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00197	CcSEcCtD
Mexiletine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00195	CcSEcCtD
Mexiletine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00195	CcSEcCtD
Mexiletine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.00195	CcSEcCtD
Mexiletine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00194	CcSEcCtD
Mexiletine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00194	CcSEcCtD
Mexiletine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00191	CcSEcCtD
Mexiletine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.0019	CcSEcCtD
Mexiletine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000269	0.0019	CcSEcCtD
Mexiletine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00186	CcSEcCtD
Mexiletine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00184	CcSEcCtD
Mexiletine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00181	CcSEcCtD
Mexiletine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00181	CcSEcCtD
Mexiletine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.0018	CcSEcCtD
Mexiletine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000254	0.0018	CcSEcCtD
Mexiletine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00179	CcSEcCtD
Mexiletine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00178	CcSEcCtD
Mexiletine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00177	CcSEcCtD
Mexiletine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00175	CcSEcCtD
Mexiletine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00175	CcSEcCtD
Mexiletine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00171	CcSEcCtD
Mexiletine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00171	CcSEcCtD
Mexiletine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00171	CcSEcCtD
Mexiletine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00169	CcSEcCtD
Mexiletine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00168	CcSEcCtD
Mexiletine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00168	CcSEcCtD
Mexiletine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00167	CcSEcCtD
Mexiletine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00167	CcSEcCtD
Mexiletine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00167	CcSEcCtD
Mexiletine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00167	CcSEcCtD
Mexiletine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00166	CcSEcCtD
Mexiletine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00166	CcSEcCtD
Mexiletine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00165	CcSEcCtD
Mexiletine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00165	CcSEcCtD
Mexiletine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00165	CcSEcCtD
Mexiletine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00163	CcSEcCtD
Mexiletine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00163	CcSEcCtD
Mexiletine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.00163	CcSEcCtD
Mexiletine—Depression—Prednisone—chronic obstructive pulmonary disease	0.00023	0.00163	CcSEcCtD
Mexiletine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00162	CcSEcCtD
Mexiletine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00159	CcSEcCtD
Mexiletine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00158	CcSEcCtD
Mexiletine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00158	CcSEcCtD
Mexiletine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.00157	CcSEcCtD
Mexiletine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00157	CcSEcCtD
Mexiletine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00157	CcSEcCtD
Mexiletine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00157	CcSEcCtD
Mexiletine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00157	CcSEcCtD
Mexiletine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00154	CcSEcCtD
Mexiletine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00154	CcSEcCtD
Mexiletine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.00152	CcSEcCtD
Mexiletine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.00152	CcSEcCtD
Mexiletine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00149	CcSEcCtD
Mexiletine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00148	CcSEcCtD
Mexiletine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00148	CcSEcCtD
Mexiletine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00146	CcSEcCtD
Mexiletine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00143	CcSEcCtD
Mexiletine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.00141	CcSEcCtD
Mexiletine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00139	CcSEcCtD
Mexiletine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00131	CcSEcCtD
Mexiletine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000183	0.0013	CcSEcCtD
Mexiletine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00129	CcSEcCtD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000177	0.00362	CbGpPWpGaD
Mexiletine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000177	0.00362	CbGpPWpGaD
Mexiletine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00123	CcSEcCtD
Mexiletine—AHR—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000172	0.00352	CbGpPWpGaD
Mexiletine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00017	0.0012	CcSEcCtD
Mexiletine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00118	CcSEcCtD
Mexiletine—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000167	0.00342	CbGpPWpGaD
Mexiletine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00118	CcSEcCtD
Mexiletine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.00339	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000163	0.00333	CbGpPWpGaD
Mexiletine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00115	CcSEcCtD
Mexiletine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00333	CbGpPWpGaD
Mexiletine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000163	0.00332	CbGpPWpGaD
Mexiletine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00114	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.00016	0.00327	CbGpPWpGaD
Mexiletine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00112	CcSEcCtD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—chronic obstructive pulmonary disease	0.000158	0.00322	CbGpPWpGaD
Mexiletine—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.0032	CbGpPWpGaD
Mexiletine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.0032	CbGpPWpGaD
Mexiletine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00111	CcSEcCtD
Mexiletine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000156	0.0011	CcSEcCtD
Mexiletine—SCN9A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000154	0.00315	CbGpPWpGaD
Mexiletine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00109	CcSEcCtD
Mexiletine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00107	CcSEcCtD
Mexiletine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00106	CcSEcCtD
Mexiletine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.00304	CbGpPWpGaD
Mexiletine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00104	CcSEcCtD
Mexiletine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.003	CbGpPWpGaD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.003	CbGpPWpGaD
Mexiletine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.00298	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000146	0.00297	CbGpPWpGaD
Mexiletine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00102	CcSEcCtD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000144	0.00295	CbGpPWpGaD
Mexiletine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.00294	CbGpPWpGaD
Mexiletine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00101	CcSEcCtD
Mexiletine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00291	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000142	0.0029	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000142	0.0029	CbGpPWpGaD
Mexiletine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00287	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000139	0.00284	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000138	0.00282	CbGpPWpGaD
Mexiletine—SCN10A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000137	0.00279	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000135	0.00275	CbGpPWpGaD
Mexiletine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000949	CcSEcCtD
Mexiletine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000948	CcSEcCtD
Mexiletine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000935	CcSEcCtD
Mexiletine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000917	CcSEcCtD
Mexiletine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000903	CcSEcCtD
Mexiletine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000903	CcSEcCtD
Mexiletine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000898	CcSEcCtD
Mexiletine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000898	CcSEcCtD
Mexiletine—SCN4A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000127	0.00259	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000127	0.00259	CbGpPWpGaD
Mexiletine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00089	CcSEcCtD
Mexiletine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000123	0.00252	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000122	0.0025	CbGpPWpGaD
Mexiletine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000858	CcSEcCtD
Mexiletine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00246	CbGpPWpGaD
Mexiletine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000851	CcSEcCtD
Mexiletine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000851	CcSEcCtD
Mexiletine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00241	CbGpPWpGaD
Mexiletine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000823	CcSEcCtD
Mexiletine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000823	CcSEcCtD
Mexiletine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00236	CbGpPWpGaD
Mexiletine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00235	CbGpPWpGaD
Mexiletine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000767	CcSEcCtD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00221	CbGpPWpGaD
Mexiletine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00221	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00221	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000107	0.00219	CbGpPWpGaD
Mexiletine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000107	0.00218	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00217	CbGpPWpGaD
Mexiletine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000747	CcSEcCtD
Mexiletine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000106	0.00216	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000105	0.00214	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000104	0.00212	CbGpPWpGaD
Mexiletine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00211	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000103	0.0021	CbGpPWpGaD
Mexiletine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00209	CbGpPWpGaD
Mexiletine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00207	CbGpPWpGaD
Mexiletine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000712	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	9.8e-05	0.002	CbGpPWpGaD
Mexiletine—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.000689	CcSEcCtD
Mexiletine—SCN5A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	9.61e-05	0.00196	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.52e-05	0.00194	CbGpPWpGaD
Mexiletine—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000662	CcSEcCtD
Mexiletine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.3e-05	0.0019	CbGpPWpGaD
Mexiletine—Rash—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.000657	CcSEcCtD
Mexiletine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.28e-05	0.000656	CcSEcCtD
Mexiletine—Headache—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.000652	CcSEcCtD
Mexiletine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.18e-05	0.00188	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	8.92e-05	0.00182	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.82e-05	0.0018	CbGpPWpGaD
Mexiletine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.76e-05	0.00179	CbGpPWpGaD
Mexiletine—Nausea—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000618	CcSEcCtD
Mexiletine—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.7e-05	0.00178	CbGpPWpGaD
Mexiletine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.64e-05	0.00177	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.64e-05	0.00176	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	8.59e-05	0.00176	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—LEP—chronic obstructive pulmonary disease	8.56e-05	0.00175	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.55e-05	0.00175	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.52e-05	0.00174	CbGpPWpGaD
Mexiletine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.38e-05	0.00171	CbGpPWpGaD
Mexiletine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.36e-05	0.00171	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.87e-05	0.00161	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.87e-05	0.00161	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.59e-05	0.00155	CbGpPWpGaD
Mexiletine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.54e-05	0.00154	CbGpPWpGaD
Mexiletine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.4e-05	0.00151	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.37e-05	0.00151	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.35e-05	0.0015	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.29e-05	0.00149	CbGpPWpGaD
Mexiletine—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.25e-05	0.00148	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.24e-05	0.00148	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—MMP9—chronic obstructive pulmonary disease	7.21e-05	0.00147	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.2e-05	0.00147	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.1e-05	0.00145	CbGpPWpGaD
Mexiletine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.1e-05	0.00145	CbGpPWpGaD
Mexiletine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.8e-05	0.00139	CbGpPWpGaD
Mexiletine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.76e-05	0.00138	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.76e-05	0.00138	CbGpPWpGaD
Mexiletine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.67e-05	0.00136	CbGpPWpGaD
Mexiletine—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.66e-05	0.00136	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.63e-05	0.00135	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.63e-05	0.00135	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.62e-05	0.00135	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.53e-05	0.00133	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	6.48e-05	0.00132	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.41e-05	0.00131	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.39e-05	0.00131	CbGpPWpGaD
Mexiletine—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.32e-05	0.00129	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.27e-05	0.00128	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.25e-05	0.00128	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.21e-05	0.00127	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.19e-05	0.00126	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.17e-05	0.00126	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.13e-05	0.00125	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.04e-05	0.00124	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.99e-05	0.00123	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.95e-05	0.00122	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.95e-05	0.00122	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.83e-05	0.00119	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.74e-05	0.00117	CbGpPWpGaD
Mexiletine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.48e-05	0.00112	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.36e-05	0.00109	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.36e-05	0.00109	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	5.34e-05	0.00109	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.17e-05	0.00106	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	5.15e-05	0.00105	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	5.15e-05	0.00105	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.11e-05	0.00104	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.08e-05	0.00104	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	5.05e-05	0.00103	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.04e-05	0.00103	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.01e-05	0.00102	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.82e-05	0.000985	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.77e-05	0.000974	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.73e-05	0.000967	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.73e-05	0.000967	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.7e-05	0.00096	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.66e-05	0.000952	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.63e-05	0.000947	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.62e-05	0.000945	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.57e-05	0.000933	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.57e-05	0.000933	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.56e-05	0.000932	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.49e-05	0.000918	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.48e-05	0.000916	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.45e-05	0.00091	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.39e-05	0.000897	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.39e-05	0.000897	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.35e-05	0.000889	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.35e-05	0.000889	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.33e-05	0.000885	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.27e-05	0.000873	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.25e-05	0.000868	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.25e-05	0.000868	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	4.24e-05	0.000867	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	4.16e-05	0.00085	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.12e-05	0.000841	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.12e-05	0.000841	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.1e-05	0.000837	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.04e-05	0.000825	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.01e-05	0.000819	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.98e-05	0.000813	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—IL6—chronic obstructive pulmonary disease	3.97e-05	0.000811	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.96e-05	0.00081	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.95e-05	0.000808	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.92e-05	0.000802	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.9e-05	0.000797	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.9e-05	0.000797	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.82e-05	0.000781	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.82e-05	0.000781	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.77e-05	0.000771	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.76e-05	0.000768	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.72e-05	0.00076	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.69e-05	0.000753	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.64e-05	0.000744	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.64e-05	0.000744	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.63e-05	0.000742	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.58e-05	0.000732	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.51e-05	0.000717	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.41e-05	0.000698	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.34e-05	0.000683	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.34e-05	0.000683	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	3.32e-05	0.000679	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.3e-05	0.000674	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	3.25e-05	0.000665	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.21e-05	0.000655	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.2e-05	0.000653	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.09e-05	0.000631	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.07e-05	0.000628	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.03e-05	0.00062	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.03e-05	0.000619	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.02e-05	0.000618	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.94e-05	0.0006	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.94e-05	0.0006	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.91e-05	0.000595	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.88e-05	0.000589	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.87e-05	0.000587	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.83e-05	0.000579	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.79e-05	0.00057	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.64e-05	0.00054	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.59e-05	0.00053	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.47e-05	0.000504	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.37e-05	0.000485	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.34e-05	0.000479	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.31e-05	0.000472	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.16e-05	0.000442	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.15e-05	0.000439	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.01e-05	0.000411	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.99e-05	0.000407	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.96e-05	0.0004	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.82e-05	0.000372	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.81e-05	0.000371	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.79e-05	0.000367	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.78e-05	0.000363	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.76e-05	0.000359	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.64e-05	0.000334	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.6e-05	0.000328	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.55e-05	0.000317	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.51e-05	0.000308	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.51e-05	0.000308	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.48e-05	0.000302	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.45e-05	0.000296	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.4e-05	0.000287	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.26e-05	0.000258	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.000257	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.25e-05	0.000255	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.24e-05	0.000253	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.23e-05	0.000252	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.21e-05	0.000248	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.000236	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.14e-05	0.000232	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.13e-05	0.000231	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000224	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.07e-05	0.000219	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.07e-05	0.000218	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.06e-05	0.000216	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.05e-05	0.000214	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.85e-06	0.000201	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.64e-06	0.000197	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.74e-06	0.000179	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.62e-06	0.000176	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.24e-06	0.000168	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.15e-06	0.000167	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.03e-06	0.000164	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.61e-06	0.000156	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	7.45e-06	0.000152	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.44e-06	0.000152	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.4e-06	0.000151	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.3e-06	0.000149	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	7.29e-06	0.000149	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.12e-06	0.000146	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.98e-06	0.000143	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.85e-06	0.00014	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.8e-06	0.000139	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.45e-06	0.000132	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.71e-06	0.000117	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.64e-06	0.000115	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.25e-06	0.000107	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.18e-06	0.000106	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.98e-06	0.000102	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.95e-06	0.000101	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.38e-06	8.96e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.19e-06	8.57e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.38e-06	6.92e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.24e-06	6.62e-05	CbGpPWpGaD
